Title |
Trends in availability and prices of subsidized ACT over the first year of the AMFm: evidence from remote regions of Tanzania
|
---|---|
Published in |
Malaria Journal, August 2012
|
DOI | 10.1186/1475-2875-11-299 |
Pubmed ID | |
Authors |
Prashant Yadav, Jessica L Cohen, Sarah Alphs, Jean Arkedis, Peter S Larson, Julius Massaga, Oliver Sabot |
Abstract |
The Affordable Medicines Facility for malaria (AMFm) is a pilot supra-national subsidy program that aims to increase access and affordability of artemisinin combination therapy (ACT) in public sector clinics and private retail shops. It is unclear to what extent the AMFm model will translate into wide scale availability and price reductions in ACT, particularly for rural, remote areas where disparities in access to medicines often exist. This study is the first to rigorously examine the availability and price of subsidized ACT during the first year of the AMFm, measured through retail audits in remote regions of Tanzania. |
X Demographics
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 50% |
United States | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 1% |
United States | 1 | 1% |
Norway | 1 | 1% |
Vietnam | 1 | 1% |
Unknown | 70 | 95% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 15 | 20% |
Student > Master | 11 | 15% |
Lecturer | 6 | 8% |
Other | 5 | 7% |
Student > Doctoral Student | 4 | 5% |
Other | 15 | 20% |
Unknown | 18 | 24% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 16 | 22% |
Pharmacology, Toxicology and Pharmaceutical Science | 7 | 9% |
Social Sciences | 7 | 9% |
Agricultural and Biological Sciences | 6 | 8% |
Nursing and Health Professions | 4 | 5% |
Other | 16 | 22% |
Unknown | 18 | 24% |